We’re kicking off 2026 on a positive note so far, and in my view, the main theme we should be watching out for this year is rotation. Early so far in January, many laggards have achieved meaningful rebounds. This isn’t just tax loss rebounds- in myWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a re ...

Market Trends & Economic Outlook - Rising oil prices due to sanctions on Venezuela and potential sanctions on Russia could impact the Fed's easing path, especially if it affects CPI data [1][2][3] - Rotation is expected to continue, with capital moving from high multiple mega-cap winners to small caps, cyclicals, and international markets [4][5] - Easy monetary policy from the Fed, including the end of quantitative tightening and rate cuts, along with fiscal policy, will likely support this trend [5][13] Investment Opportunities & Sector Analysis - Small caps, particularly the S&P 600, are favored due to undervaluation and historical outperformance during rate-cutting cycles [5][7] - Fiscal policy and tax bills are expected to benefit R&D-intensive small caps, but high-quality companies with strong balance sheets and consistent cash flows are preferred [8] - Financials are viewed optimistically, especially regional banks, with strong fundamental backdrop and potential for further growth [9] - Financials are experiencing the second strongest earning season in the S&P 500, with 25% year-over-year earnings growth expected, driven by steepening yield curve and capital markets activity [10] - Banks, insurance, and banks tied to capital markets activity are attractive within the financials sector [11] IPO Market - Increased liquidity and easy monetary policy are creating a positive environment for the IPO market [13] - The upcoming Medline IPO, the largest of the year, and the resolution of the government shutdown are expected to release a bottleneck of IPOs [12] Consumer Spending & Tax Refunds - Anticipated tax refunds in the range of $100 billion to $150 billion next year, or $1,000 to $2,000 per household, are expected to boost consumer-sensitive sectors [14][16] - Consumer discretionary, home builders, and banks are expected to benefit from the influx of tax refunds in early 2026 [15][16]

NASDAQ on pace to snap a seven-month winning streak as tech drags. Joining me now, markets and data editor Jared Blickery, as well as Michelle Schneider, market gauge. com chief strategist.Jared, I want to start with you. Give us a look at the month here because we saw a lot of damage within tech and that looks like it's going to drag the NASDAQ lower on the month. >> You bet.And let's start with the uh Wi-Fi Interactive. And I'm going to pull up the month to date and this is going to be as of the close Wed ...

whether an even greater rotation is coming. Now joining us for the hour Josh Brown, Carrie Firestone, Bill Baruch, Jenny Herrington. We'll check the markets where the big story is, the fact that we are down across the board.And if we throw up what the interest rate complex looks like, that could very well be a culprit today. No doubt about that. As we've got rates Get from the Fed in December.That's that seems to be the story today. No. Yeah.I think it's actually part of a bigger story. And I was talking to ...

Core Viewpoint - The biotech sector is showing strong momentum, with significant potential for continued growth, particularly in the context of upcoming mergers and acquisitions (M&A) in 2026 [3][11]. Group 1: Sector Performance - The biotech sector is performing comparably to major tech stocks, indicating a competitive landscape [1]. - Companies like Gilead and Merck are reaching all-time highs, while Bristol Myers is also recovering [2]. - Historical valuations for biotech and healthcare are at historic lows compared to the past five years, suggesting a value opportunity [3]. Group 2: Valuation Insights - The forward price-to-earnings (PE) ratio for the healthcare sector is currently around 18, below the historical average of over 20 [5]. - There is a significant valuation gap, with some companies trading at single-digit or low double-digit multiples, indicating potential undervaluation [6][10]. - The healthcare sector typically represents 10-15% of a traditional portfolio allocation, but many investors are currently underweight in this area [6]. Group 3: Market Dynamics - The recent rotation in the market has favored healthcare, with notable inflows observed in October, marking one of the largest rotation days in years [9]. - The Trump administration's stance appears to have eased pressures on companies like United Healthcare, contributing to a more favorable investment environment [9]. - The potential for M&A activity in the biotech space is high, with companies positioned for strategic acquisitions [11].

Welcome to the great rotation. https://t.co/HJrEV4wOK4Will (@WClementeIII):Am I hallucinating or are we literally watching a gold to Bitcoin rotation on the tape this morning ...

JUST IN: Gold hits most overbought levels ever on its monthly RSI.Rotation into Bitcoin next? https://t.co/zpfcni5nQQ ...

wHaTs tHe neXt rOtAtIoN https://t.co/bxwkuSksmB ...

Rotation incoming?#BTC cooling, #alts starting to breathe.Keep your eyes open 👀 NFA ...

Rotation, rotation, rotation.Profits from #BTC → #ETH → #Alts → Low caps.It’s the playbook. ...